Images reveal how some antibodies may block SARS-CoV-2 infection.

Scientists at the Stanford Synchrotron Radiation Lightsource will study plastics and biologically-motivated processes that break them down in hopes of finding more efficient ways to “upcycle” them.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

University of Alberta researchers worked with SLAC X-ray scientists to explore the potential of a feline coronavirus drug that may be effective against SARS-CoV-2.

Stanford and SLAC scientists studying the varicella zoster virus found that an antibody that blocks infection doesn’t work exactly as they’d thought.

For the first time, scientists have revealed the steps needed to turn on a receptor that helps regulate neuron firing. The findings might help researchers understand and someday treat addiction, psychosis and other neuropsychological diseases.

Researchers expect the new method to answer fundamental questions in biology and materials science. First up: Images showing molecules that help guide cell division in bacteria.

The lab is responding to the coronavirus crisis by imaging disease-related biomolecules, developing standards for reliable coronavirus testing and enabling other essential research.

The giant cavity, in a protein that transports nutrients across the cell membrane, is unlike anything researchers have seen before.

A better understanding of this phenomenon, which is crucial to many processes that occur in biological systems and materials, could enable researchers to develop light-sensitive proteins for areas such as biological imaging and optogenetics.

What they learned could lead to a better understanding of how antibiotics are broken down in the body, potentially leading to the development of more effective drugs.